NCT00246155

Study on the Effects of Botulinum Toxin Type A on Back Muscle in Chronic Low Back Pain

A Prospective Study to Evaluate the Potential Effects on Function and Size in Back Muscle After Injection of Botulinum Toxin Type A (Dysport®) in the Treatment of Chronic Low Back Pain

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 35 (actual)
• Sponsor: Ipsen · Industry
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to analyse the changes in back muscle size and strength following use of Dysport®, and to establish whether there is any association between pain reduction and change in strength, in patients suffering from chronic low back pain.

Conditions

• Low Back Pain

Interventions

Type	Name	Description
BIOLOGICAL	Botulinum toxin type A

Timeline

• Start date: 2005-01-01
• Primary completion: 2005-07-01
• Completion: 2005-07-01
• First posted: 2005-10-31
• Last updated: 2019-07-26

Locations

1 site across 1 country: South Korea